GNH USA

Europe — EMA

Ipratropium/Salbutamol Cipla

GNH USA supplies Ipratropium/Salbutamol Cipla (Ipratropium bromide / Salbutamol), a bronchodilator for COPD and asthma bronchospasm.

Salbutamol, Ipratropium Bromide Monohydrate

Request sourcing

1
Pack/s

What is Salbutamol, Ipratropium Bromide Monohydrate?

Ipratropium bromide and Salbutamol, the active ingredients in Ipratropium/Salbutamol Cipla, are bronchodilators (anticholinergic + β2‑agonist) presented as an inhalation product for inhalation use. They are indicated for the relief of bronchospasm in obstructive airway diseases such as COPD and asthma. GNH USA supplies Ipratropium/Salbutamol Cipla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Salbutamol, Ipratropium Bromide Monohydrate used for?

Ipratropium/Salbutamol Cipla is a combination bronchodilator used in obstructive airway diseases.

- Chronic obstructive pulmonary disease (COPD): provides rapid relief of bronchospasm and improves airflow. - Asthma: reduces bronchoconstriction and helps control acute symptoms. - Acute bronchospasm: delivers quick bronchodilation to ease breathing difficulties.

What are the side effects of Salbutamol, Ipratropium Bromide Monohydrate?

Common Side Effects: - Cough or throat irritation: mild discomfort during inhalation. - Tremor: transient shaking, often of the hands. - Headache: mild to moderate intensity. - Dry mouth: reduced salivation after use.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening of breathing difficulty. - Angioedema: swelling of face, lips, or tongue. - Tachyarrhythmia: rapid or irregular heart rhythm. - Severe allergic reaction: rash, itching, or anaphylaxis.

What precautions apply to Salbutamol, Ipratropium Bromide Monohydrate?

Before using Ipratropium/Salbutamol Cipla, consider the following precautions: - Cardiac history: monitor for tachyarrhythmias in patients with heart disease. - Hypersensitivity: avoid if known allergy to ipratropium, salbutamol, or formulation components. - Cardiovascular disease: use with caution in severe hypertension or coronary artery disease. - Dosage limits: do not exceed the prescribed frequency; follow healthcare provider instructions. - Pregnancy and lactation: discuss potential risks with a qualified professional before use. - Store at room temperature: keep in the original container, protect from moisture and light.

What does Salbutamol, Ipratropium Bromide Monohydrate interact with?

Ipratropium/Salbutamol Cipla may interact with other medicines as follows:

Major Interactions (Avoid): - Beta‑blockers: may diminish bronchodilator effectiveness. - MAO inhibitors: increased risk of severe bronchospasm. - Tricyclic antidepressants: can heighten cardiovascular side effects.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate hypokalemia; monitor electrolyte levels. - Theophylline: additive bronchodilator effect; observe for toxicity. - Other anticholinergics: increased anticholinergic load; watch for dry mouth and urinary retention.

Frequently asked questions

What is Ipratropium/Salbutamol Cipla used for?+
Ipratropium/Salbutamol Cipla is an inhaled combination bronchodilator indicated for the relief of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and asthma. It helps open the airways, making breathing easier during acute episodes or as part of a maintenance regimen prescribed by a healthcare professional.
How does the active ingredients work?+
Ipratropium bromide blocks muscarinic receptors on airway smooth muscle, preventing acetylcholine‑induced constriction. Salbutamol activates β2‑adrenergic receptors, causing smooth‑muscle relaxation. The simultaneous inhibition of bronchoconstriction and promotion of bronchodilation produces a synergistic effect that improves airflow in obstructive airway conditions.
What is the usual dose?+
The dosage of Ipratropium/Salbutamol Cipla is determined by the prescribing clinician based on the patient’s age, disease severity, and response to therapy. The prescriber will specify the number of inhalations, frequency, and duration appropriate for each individual case.
Is it safe in pregnancy or breastfeeding?+
Safety data for Ipratropium/Salbutamol Cipla during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Pregnant or nursing patients should discuss use with their healthcare provider.
How do I order Ipratropium/Salbutamol Cipla from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, indicating the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the team will respond with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does it compare with other bronchodilator options?+
Compared with monotherapy agents such as salbutamol alone or ipratropium alone, the combination provides additive bronchodilation, often resulting in faster symptom relief and improved lung function. This dual mechanism can be advantageous for patients who require both rapid and sustained airway opening, reducing the need for multiple separate inhalers.
What are the storage and handling requirements?+
Store Ipratropium/Salbutamol Cipla at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain potency.
How is the medication administered?+
The product is delivered by inhalation, typically using a nebulizer or a metered‑dose inhaler as directed by the prescriber. The patient should inhale slowly and deeply, hold the breath for a few seconds if possible, and then exhale. Proper technique ensures optimal drug deposition in the lungs.
What are the most serious risks to watch for?+
Serious adverse events include paradoxical bronchospasm (worsening of breathing difficulty), severe allergic reactions such as angioedema or anaphylaxis, and cardiac arrhythmias, especially in patients with underlying heart disease. Any sudden worsening of symptoms or signs of an allergic reaction should prompt immediate medical attention.
Who should not use Ipratropium/Salbutamol Cipla?+
The medication should be avoided in individuals with known hypersensitivity to ipratropium, salbutamol, or any excipients in the formulation. Caution is also advised for patients with severe narrow‑angle glaucoma, uncontrolled cardiovascular disease, or those taking certain interacting medications without close monitoring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Salbutamol, Ipratropium Bromide Monohydrate
Route
Inhalation Use
Manufacturer
Cipla Europe Nv
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU